microbio &lt;mrc> plans acquisition, financing microbiological research corp entered letter intent proposed business combination privately owned &lt;datagene scientific laboratories inc>, &lt;milex corp> newly formed company, stock swap. received 100,000 dlrs sale convertible note ventana growth fund part 1,100,000 equity financing plan ventana. plan, minimum 400,000 dlrs maximum mln dlrs additional capital provided fund combined operations companies. microbiological maximum additional capital raised, 49 pct 4,550,00 shares common outstanding combined company, datagene holders 29 pct, ventana 13 pct. remaining pct held milex shareholder norman monson, chief executive officer combined companies.